Back to Authors

Torres, Vicente E.

https://orcid.org/0000-0003-2008-1576

Mayo Clinic

Mayo Clinic

Citations 132

Vesicoureteral Reflux in the Adult. III. Surgical Correction: Risks and Benefits
Malek, Reza S., Svensson, Jan, Neves, Ricardo J., Torres, Vicente E.

Journal of Urology | June 30, 2017 | Volume: 130 | Issue: 5 | Pages: 882-886

10.1016/s0022-5347(17)51549-9 Get It

Vesicoureteral Reflux in the Adult. II. Nephropathy, Hypertension and Stones
Malek, Reza S., Svensson, Jan, Torres, Vicente E.

Journal of Urology | June 30, 2017 | Volume: 130 | Issue: 1 | Pages: 41-44

10.1016/s0022-5347(17)50943-x Get It

Vesicoureteral Reflux in the Adult. I. Factors in Pathogenesis
Malek, Reza S., Svensson, Jan, Torres, Vicente E.

Journal of Urology | June 30, 2017 | Volume: 130 | Issue: 1 | Pages: 37-40

10.1016/s0022-5347(17)50942-8 Get It

Vesicoureteral Reflux in the Adult. IV. Medical versus Surgical Management
Neves, Ricardo J., Malek, Reza S., Svensson, Jan, Torres, Vicente E.

Journal of Urology | June 30, 2017 | Volume: 132 | Issue: 5 | Pages: 882-885

10.1016/s0022-5347(17)49933-2 Get It

Efficacy of Ganciclovir in Liver and Kidney Transplant Recipients with Severe Cytomegalovirus Infection
Paya, C. V., Hermans, Paul E., Smith, Thomas F., Rakela, Jorge , Wiesner, Russell H., Krom, Ruud A. F., Sterioff, Sylvester, Wilkowske, Conrad J., Torres, Vicente E.

Journal of Urology | June 30, 2017 | Volume: 141 | Issue: 6 | Pages: 1505-1505

10.1016/s0022-5347(17)41371-1 Get It

The regulatory 1α subunit of protein kinase A modulates renal cystogenesis
Ye, Hong , Constans, Megan, Sussman, Caroline R. , Irazabal, María V. , Harris, Peter C. , Kirschner, Lawrence S. , Torres, Vicente E. , Constans, Megan M, Ye, Hong, Wang, Xiaofang , Chebib, Fouad T. , Young, William F. , Harris, Peter C , Torres, Vicente E , Irazabal, Maria V , Sussman, Caroline R.

American Journal of Physiology-Renal Physiology | June 14, 2017 | Volume: 313 | Issue: 3 | Pages: F677-F686

10.1152/ajprenal.00119.2017 Get It

The failure of the polycystins (PCs) to function in primary cilia is thought to be responsible for autosomal dominant polycystic kidney disease (ADPKD). Primary cilia integrate multiple cellular signaling pathways, including calcium, cAMP, Wnt, and Hedgehog, which control cell proliferation and differentiation. It has been proposed that mutated PCs result in reduced intracellular calcium, which in turn upregulates cAMP, protein kinase A (PKA) signaling, and subsequently other proliferative signaling pathways. However, the role of PKA in ADPKD has not been directly ascertained in vivo, although the expression of the main regulatory subunit of PKA in cilia and other compartments (PKA-RIα, encoded by PRKAR1A) is increased in a mouse model orthologous to ADPKD. Therefore, we generated a kidney-specific knockout of Prkar1a to examine the consequences of constitutive upregulation of PKA on wild-type and Pkd1 hypomorphic ( Pkd1 RC ) backgrounds. Kidney-specific loss of Prkar1a induced renal cystic disease and markedly aggravated cystogenesis in the Pkd1 RC models. In both settings, it was accompanied by upregulation of Src, Ras, MAPK/ERK, mTOR, CREB, STAT3, Pax2 and Wnt signaling. On the other hand, Gli3 repressor activity was enhanced, possibly contributing to hydronephrosis and impaired glomerulogenesis in some animals. To assess the relevance of these observations in humans we looked for and found evidence for kidney and liver cystic phenotypes in the Carney complex, a tumoral syndrome caused by mutations in PRKAR1A. These observations expand our understanding of the pathogenesis of ADPKD and demonstrate the importance of PRKAR1A highlighting PKA as a therapeutic target in ADPKD.
Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials
Brosnahan, Godela , Rahbari-Oskoui, Frederic F. , Patterson, Charity G. , Bae, Kyongtae T. , Schrier, Robert W., Braun, William E. , Chapman, Arlene B., Flessner, Michael F., Harris, Peter C. , Steinman, Theodore I., Torres, Vicente E. , Abebe, Kaleab Z , Perrone, Ronald D. , Harris, Peter C , Torres, Vicente E , Rahbari-Oskoui, Frederic F

Current Hypertension Reviews | May 2, 2017 | Volume: 13 | Issue: 2 | Pages: No page available

10.2174/1573402113666170427142815 Get It

Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial
Gall, Émilie Cornec-Le , Blais, Jaime D., Irazabal, María V. , Devuyst, Olivier , Gansevoort, Ron T. , Perrone, R. D., Chapman, Arlene B., Czerwiec, Frank S., Ouyang, John , Heyer, Christina M., Senum, Sarah R. , Meur, Yannick Le , Torres, Vicente E. , Harris, Peter C. , Cornec-Le Gall, Emilie, Harris, Peter C , Torres, Vicente E , Senum, Sarah R , Irazabal, Maria V , Cornec-Le Gall, Emilie , Devuyst, Olivier; https://orcid.org/0000-0003-3744-4767

Nephrology Dialysis Transplantation | April 20, 2017 | Volume: 33 | Issue: 4 | Pages: 645-652

10.1093/ndt/gfx188 Get It

Pharmacokinetics and Pharmacodynamics of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Phase 2 Trials for Dose Selection in the Pivotal Phase 3 Trial
Shoaf, Susan E. , Chapman, Arlene B., Torres, Vicente E. , Ouyang, John , Czerwiec, Frank S., Torres, Vicente E

The Journal of Clinical Pharmacology | February 20, 2017 | Volume: 57 | Issue: 7 | Pages: 906-917

10.1002/jcph.880 Get It

Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial
Torres, Vicente E. , Chapman, Arlene B., Devuyst, Olivier , Gansevoort, Ron T. , Dandurand, Ann, Ouyang, John , Czerwiec, Frank S., Blais, Jaime D., Investigators, for the TEMPO 4:4 Trial, Perrone, Ronald D. , Investigators, for the TEMPO 4:4 Trial, Torres, Vicente E , Devuyst, Olivier; https://orcid.org/0000-0003-3744-4767

Nephrology Dialysis Transplantation | February 18, 2017 | Volume: 33 | Issue: 3 | Pages: 477-489

10.1093/ndt/gfx043 Get It